Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study.
Saved in:
| Title: | Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study. |
|---|---|
| Authors: | Gladstone J; Neurology, Cleveland Clinic Canada, Toronto, Ontario, Canada., Chhibber S; Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada., Minhas J; Real-world Solutions, IQVIA, Kirkland, Québec, Canada., Neish CS; Real-world Solutions, IQVIA, Kirkland, Québec, Canada., Power GS; Real-world Solutions, IQVIA, Kirkland, Québec, Canada., Lan Z; Real-world Solutions, IQVIA, Kirkland, Québec, Canada., Rochdi D; Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, Québec, Canada., Lanthier-Martel J; Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, Québec, Canada., Bastien N; Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, Québec, Canada. |
| Source: | Headache [Headache] 2022 Jan; Vol. 62 (1), pp. 78-88. Date of Electronic Publication: 2021 Nov 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-4610 (Electronic) Linking ISSN: 00178748 NLM ISO Abbreviation: Headache Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1526-4610 |
|---|---|
| DOI: | 10.1111/head.14218 |
